Marc Wilson
Förmögenhet: 4 M $ per 2026-06-30
Förmögenhet: 4 M $ per 2026-06-30
Marc J.
S.
Wilson formerly worked at Trius Therapeutics, Inc., as Accounting Director & Controller from 2010 to 2014, Cidara Therapeutics, Inc., as Chief Accounting Officer & Vice President from 2014 to 2018, and Crinetics Pharmaceuticals, Inc., as Chief Financial Officer from 2018 to 2025.
Mr. Wilson received his undergraduate degree from College of the Holy Cross (Massachusetts).
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-08 | 105 237 ( 0,1 % ) | 4 M $ | 2026-06-30 |
| Företag | Position | Slut |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2025-02-28 |
| CIDARA THERAPEUTICS | Comptroller/Controller/Revisor | 2018-01-03 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Comptroller/Controller/Revisor | 2014-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån